Myeloma Therapy
Treosulfan shows promise for multiple myeloma treatment
Published in Blood Weekly, October 30th, 2003
"Multiple myeloma is a non-curable hematological disease involving transformed plasma cells," scientists in Germany explained. "High rates of complete remission can be achieved with autologous peripheral blood stem-cell transplantation."
"Treosulfan is an alkylating substance that has been used in the treatment of ovarian carcinomas for many years," and "has a favorable side-effect profile even at high-dose protocols," noted G. Meinhardt and colleagues at the University of Muenchen Hospital. They conducted a study "to evaluate the effect of treosulfan on myeloma cells."
"The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-10-30)
More Articles from Blood Weekly
- Stem-Cell Transplantation
Costimulation blockade induces hematopoietic chimerism, central tolerance in SCT patients - Stem-Cell Transplantation
Rituximab active against refractory chronic GVHD - Stem-Cell Research
A58 oncogene can immortalize hematopoietic cells - Stem-Cell Research
Hematopoietic and mature blood cells can differentiate into cardiomyocytes - Transfusion Medicine
Dipyridamole improves efficacy of plasma exchange in TTP patients - Anthrax
$3.5M grant from U.S. government used for drug to treat anthrax exposure - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
